title: Epidermal growth factor receptor inhibitors: current status and future directions.
authors.affiliation: Investigational Drug Branch, Cancer Therapy Evaluation Program, National Cancer Institute, Rockville, Maryland, USA.
authors.forename: Helen X
authors.initials: HX
authors.lastname: Chen
authors.forename: Jessica N
authors.initials: JN
authors.lastname: Cleck
authors.forename: Rochelle
authors.initials: R
authors.lastname: Coelho
authors.forename: Janet E
authors.initials: JE
authors.lastname: Dancey
mesh_terms: D000970:Antineoplastic Agents / Q000138:chemical synthesis / Q000627:therapeutic use; D014408:Biomarkers, Tumor / Q000037:antagonists & inhibitors / Q000235:genetics / Q000502:physiology; D035843:Biomedical Research / Q000379:methods / Q000639:trends; D002626:Chemistry, Pharmaceutical / Q000639:trends; D002986:Clinical Trials as Topic / Q000379:methods* / Q000639:trends*; D015195:Drug Design; D066246:ErbB Receptors / Q000037:antagonists & inhibitors* / Q000235:genetics / Q000502:physiology; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy* / Q000209:etiology / Q000235:genetics; D047428:Protein Kinase Inhibitors / Q000138:chemical synthesis / Q000627:therapeutic use*
chemical_list: D000970:Antineoplastic Agents; D014408:Biomarkers, Tumor; D047428:Protein Kinase Inhibitors; D066246:ErbB Receptors